Value of delayed hypersensitivity index in patients with malignancy.
A delayed hypersensitivity index can be obtained by standardized in vivo testing with available antigens. Recall antigens and DNCB to measure the afferent limb can be used to assess this important body function. The index is a valid indicator of cellular immunity, which is important as a dynamic indicator in many medical conditions and in treating patients with malignancy.